Leprosy: Clinical Trials

52 trials for Leprosy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 9 unknown, 6 recruiting, 3 not yet recruiting. 18 Not applicable, 11 Phase 2, 8 Phase 1, 4 Phase 3, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 8, Recruiting 4, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Terminated 1
Phase 211Completed 7, Unknown 2, Recruiting 1, Withdrawn 1
Phase 18Completed 5, Unknown 2, Withdrawn 1
Phase 34Completed 2, Recruiting 1, Unknown 1
Phase 44Completed 3, Unknown 1

Follow Leprosy: new trials by email Literature Review of Leprosy trials Research Report on Leprosy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases
Not applicableNot yet recruitingKenya Medical Research Institute24202026-05-012026-04-02
Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)
Leprosy, Hansen's Disease
Not yet recruitingCaja Costarricense de Seguro Social1302026-05-012026-03-09
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
Ultrasound-Guided Ulnar Perineural Subcutaneous Aspirate - Leprosy, Leprosy Neuropathy
Not applicableRecruitingUniversity of Brasilia1082026-01-012026-04-07
Integrating Mental Health Into Neglected Tropical Disease Care in Ghana
WHO Essential Care package for mental health and NTDs - Leprosy, Lymphatic Filariases
Not applicableNot yet recruitingLiverpool School of Tropical Medicine2002025-11-012025-11-25
Leprosy Active Searching Trial in Brazil
Implementing active-case finding strategies - Leprosy
Not applicableCompletedHospital Alemão Oswaldo Cruz3232025-06-012026-08-04
Auricular Electroacupuncture and Auricular Acupuncture With Health Education for Pain in Leprosy
Auricular Electroacupuncture, Auricular Acupuncture, Health Education - Leprosy
Not applicableCompletedUniversidade Federal de Pernambuco162025-04-012026-10-07
Trauma-Informed Motivational Interviewing in Rural Dwelling Samples
Trauma-Informed Motivational Interviewing - Discrimination, Perceived
Not applicableRecruitingAlexandria University702025-03-012025-04-23
Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy
LepVax (2 μg LEP-F1 + 5 μg GLA-S): Low dose, LepVax (10 μg LEP-F1 + 5 μg GLA-SE): High dose, Placebo Comparator: Placebo - Leprosy
Phase 1UnknownThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)542025-01-022024-10-04
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients
Dapsone - Leprosy, Mycobacterium Leprae Infection
Not applicableRecruitingSouth Valley University502024-12-202025-02-11
TGF β 1 Expression Related Gene Polymorphism
Measurement of TGF- β1 in leprosy patients - Leprosy
UnknownAswan University602024-07-102024-11-12
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
LEP-F1 + GLA-SE, Placebo - Leprosy
Phase 1 / Phase 2UnknownThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)1422024-02-012023-06-13
Serum Irisin Level In Leprosy Patients
Serum Irisin - Leprosy
CompletedAswan University582024-01-012024-11-08
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
BE-PEP Bedaquiline, SDR-PEP Rifampicin, BE-PEP Rifampicin - Leprosy
Phase 3RecruitingInstitute of Tropical Medicine, Belgium1240002023-03-222026-05-19
Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum
Methotrexate, Placebo, Prednisolone - Erythema Nodosum Leprosum
Not applicableActive not recruitingLondon School of Hygiene and Tropical Medicine5502023-01-152025-09-10
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
Metformin, Placebo - Leprosy, Leprosy, Multibacillary
Phase 2RecruitingOxford University Clinical Research Unit Indonesia1662022-10-012025-08-07
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
BE-PEP (Bedaquiline), SDR-PEP, BE-PEP (Rifampicine) - Leprosy
Phase 2CompletedInstitute of Tropical Medicine, Belgium3132022-07-142024-08-28
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
Traditional Chinese Medicine mouthwash, Dilute 50 times of Traditional Chinese Medicine mouthwash - Leprosy, Hansen's Disease
Not applicableCompletedLo-Sheng Sanatorium412021-10-012024-03-13
The Effect of "Jinchuang Ointment" (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.
"Jingchuang Ointment"(JCO), Regular Treatment - Leprosy, Hansen's Disease
Not applicableCompletedLo-Sheng Sanatorium202021-08-072024-03-13
Novel Interventions and Diagnostic Tests for Leprosy
Rifampin - Leprosy
Not applicableRecruitingAnnemieke Geluk11002020-03-042025-09-10
Epidemiology of Leprosy in French Guiana
standardised exposure questionnaire - Hansen's Disease
UnknownCentre Hospitalier de Cayenne3682020-01-072021-09-01

Showing 20 of 52. Sign in to see all of them.

Narrower conditions

Leprosy, Multibacillary (5)  ·  Leprosy, Lepromatous (4)  ·  Buruli Ulcer (3)  ·  Elephantiasis, Filarial (3)  ·  Yaws (3)  ·  Communicable Diseases (2)  ·  Neglected Diseases (2)  ·  Onchocerciasis (2)  ·  Tuberculosis (2)  ·  Acne Vulgaris (1)  ·  Cerebral Palsy (1)  ·  Disease (1)  ·  Elephantiasis (1)  ·  Health Education (1)

Broader conditions

Actinomycetales Infections (52)  ·  Bacterial Infections (52)  ·  Bacterial Infections and Mycoses (52)  ·  Gram-Positive Bacterial Infections (52)  ·  Infections (52)  ·  Mycobacterium Infections (52)  ·  Mycobacterium Infections, Nontuberculous (52)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pathologic Processes (6)  ·  Disease Attributes (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Nervous System Diseases (4)  ·  Signs and Symptoms (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)

Interventions

Cyclosporine (4)  ·  Dapsone (4)  ·  Prednisolone (4)  ·  Rifampin (4)  ·  Adrenal Cortex Hormones (3)  ·  Clofazimine (3)  ·  Low-Level Light Therapy (2)  ·  Methotrexate (2)  ·  bedaquiline (2)  ·  Acupuncture, Ear (1)  ·  Amitriptyline (1)  ·  CC-11050 (1)  ·  Counseling (1)  ·  Exercise (1)  ·  Health Promotion (1)

Sponsors

London School of Hygiene and Tropical Medicine (6)  ·  Institute of Tropical Medicine, Belgium (4)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Aswan University (2)  ·  Colorado State University (2)  ·  Lo-Sheng Sanatorium (2)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (2)  ·  University of Brasilia (2)  ·  University of Sao Paulo (2)  ·  Access to Advanced Health Institute (AAHI) (1)  ·  Alexandria University (1)  ·  Annemieke Geluk (1)  ·  Caja Costarricense de Seguro Social (1)  ·  Centre Hospitalier de Cayenne (1)  ·  Chittagong Medical College (1)

Countries

Brazil (12)  ·  Ethiopia (6)  ·  United States (5)  ·  Bangladesh (4)  ·  Comoros (4)  ·  Egypt (4)  ·  Indonesia (4)  ·  Nepal (3)  ·  Philippines (3)  ·  Taiwan (2)  ·  China (1)  ·  Colombia (1)  ·  Costa Rica (1)  ·  Democratic Republic of the Congo (1)  ·  French Guiana (1)

Top investigators

Diana NJ Lockwood, MBChB (2)  ·  Wei-Hung Hsu (2)  ·  Younoussa Assoumani (2)  ·  Abdallah Mahmoud Abdallah, Professor (1)  ·  Abdul H Salim, MBBS (1)  ·  Annemieke Geluk, PhD (1)  ·  Arnold M Henson, MD (1)  ·  Bertrand Cauchoix, MD (1)  ·  Bouke C de Jong, MD,PhD (1)  ·  Bouke de Jong, MD, PhD (1)  ·  Claudio G Salgado, Dr (1)  ·  Corey Casper, MD, MPH (1)  ·  Daniel Andrade, PhD (1)  ·  Diana Lockwood, MBChB (1)

Results publications

PMID 24874401, PMID 35850123, PMID 16248209, PMID 19571027, PMID 20698989, PMID 21756569, PMID 22826694, PMID 22846185, PMID 25389921, PMID 25530971, PMID 25771459, PMID 25884704, PMID 28222139, PMID 28704363, PMID 28841158, PMID 29867930, PMID 31148869, PMID 31389998, PMID 31805862, PMID 37161571, PMID 38697216, PMID 38762282, PMID 38808319, PMID 39432509, PMID 39665652, PMID 41093045, PMID 42152617, PMID 42308518, PMID 42546085, PMID 42814788

NIH funding

5UL1RR024982-02 (1)